MAP2K7 and leukemia: For early naïve culture we used 5iLA conditions (MEK inhibitor, GSK3 inhibitor, ROCK inhibitor, BRAF inhibitor and SRC inhibitor with human leukemia inhibitor factor (hLIF) and Activin A; [11]).